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Abstract
RNA interference (RNAi) and gene inactivation are extensively used biological terms in
biomedical research. Two categories of small ribonucleic acid (RNA) molecules, viz.,
microRNA (miRNA) and small interfering RNA (siRNA) are central to the RNAi. There
are various kinds of algorithms developed related to RNAi and gene silencing. In this
book chapter, we provided a comprehensive review of various machine learning and
association rule mining algorithms developed to handle different biological problems
such as detection of gene signature, biomarker, gene module, potentially disordered
protein, differentially methylated region and many more. We also provided a comparative
study of different well-known classifiers along with other used methods. In addition, we
demonstrated the brief biological information regarding the immense biological chal-
lenges for gene activation as well as their advantages, disadvantages and possible thera-
peutic strategies. Finally, our study helps the bioinformaticians to understand the overall
immense idea in different research dimensions including several learning algorithms for
the benevolent of the disease discovery.
Keywords: machine learning, association rule mining, RNAi, gene silencing,
multi-omics data
1. Introduction
RNAi [1] is an innate biological process in which RNA molecules inhibit gene expression or
translation [2] by suppressing targeted mRNA molecules. Since the discovery of RNAi by
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Andrew Fire and Craig Mello, it has become evident that RNAi has immense potential in
suppression of desired genes [3]. The first evidence that double-stranded RNA (dsRNA) could
achieve efficient gene silencing through RNAi came from studies on the nematode
Caenorhabditis elegans [4] and Drosophila melanogaster [5], which lead toward understanding
the biochemical nature of the RNAi pathway. Two types of small ribonucleic acid (RNA)
molecules—microRNA (miRNA) and small interfering RNA (siRNA)—are central to RNAi
[6]. To compare two types of elicit RNAi, the siRNA must be fully complementary to its target
mRNA, whereas, miRNA only needs to be partially complementary to its target mRNA.
In organisms like C. elegans and D. melanogaster, RNAi can be induced by introducing long
dsRNA complementary to the target mRNA to be degraded, however, in mammalian cells and
organisms, introducing dsRNA longer than 30 bp activates a potent antiviral response. To solve
this limitation, siRNAs are used to induce RNAi in mammalian cells and organisms [7–9].
The discovery of both siRNA and miRNA provides a new therapeutic approach [10, 11] for the
treatment of diseases by targeting genes that have undesired mutated or overexpression of
normal genes. The RNAi Process is as following. SiRNAs that induce the degradation of
specific endogenous is very common phenomenon in eukaryotic cells to inhibit protein pro-
duction at post transcriptional level [12]. The RNAi process is initiated by short dsRNAs, 21–25
nucleotides that lead to the sequence specific inhibition of their homologous mRNAs. These
siRNAs are normally produced in cells from cleavage of longer dsRNA precursors by Dicer
that is a ribonuclease III family member. The cleaved parts are incorporated into a multi-
component nuclease complex known as the RNA-induced silencing complexes (RISC), which
contain the splicing protein Argonaute-2 (Ago-2) [13]. The ssRNA derived from the short
dsRNA acts as a antisense strand directing the complex to the specific target mRNA; in where
a RISC-associated endoribonuclease cleavages the target mRNA [14]. Therapeutic approaches
based on siRNA involve the introduction of a synthetic siRNA into the target cells to elicit
RNAi, thereby inhibiting the expression of a specific messenger RNA (mRNA) to produce a
gene silencing effect [15]. RNAi is beneficial in accelerating cures in medicine, especially when
a disease is thought to due to a defective gene [16]. For historical perspective, the first applica-
tion of RNAi therapy was in age-related macular degeneration (AMD) by using siRNAs to
suppress the vascular endothelial growth factor (VEGF) pathway that causes abnormal growth
of blood vessels behind the retina, carried out directly to the patient’s eye [17]. RNAi tech-
niques have been used against the spread of tumor growth and increasing its sensitization
toward drug treatment, RNAi technology will be beneficial to selectively affect cancer cells
without damaging normal cells as the RNAi therapy against cancer cells is used for directly
targeting the oncogenes; and therefore, found to stop progression and invasion of the tumor
cells [18, 19] and also increase the sensitization of tumor against drug, as mentioned earlier
[20]. As RNAi can silence disease-associated genes in tissue culture and animal models, the
development of RNAi-based reagents for therapeutic applications involves technological
enhancements that improve siRNA stability and delivery in vivo [21], while minimizing off-
target and nonspecific effects.
A number of different approaches have been developed for the in vivo delivery of siRNA,
among which, rapid infusion by hydrodynamic injection of siRNA achieves the best delivery
in rodents [22]. However, this way, the delivery is restricted to highly vascularized tissues,
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such as the liver [23] and also, it is currently not a viable method for delivery in human clinical
studies. Lipid-based in vivo applications have been devised [24], which have been used exten-
sively for cell culture experiments, with some issues, like the cationic nature of the lipids used
in cell culture leads to aggregation when used in animals and results in rapid serum clearance
and lung accumulation. Even then, there are an increasing number of reports citing success
with lipid-mediated delivery of siRNAs in vivo. To improve the delivery of siRNA into human
liver cells [25] without transfection agents, lipophilic siRNAs were conjugated with derivatives
of cholesterol, lithocholic acid, or lauric acid, where the lipid moieties were covalently linked to
the 50-ends of the RNAs using phosphoramidite chemistry [26]. These could down-regulate the
expression of a LacZ expression construct. By conjugating cholesterol to the 30-end of the sense
strand of siRNA by means of a pyrrolidine linker, the pharmacological properties of siRNA
molecules was improved by Soutschek et al. [27]. Advantages of cholesterol attachments are
evident as being more resistant to nuclease degradation, more stable in the blood by increasing
binding to human serum albumin and increased uptake of siRNA molecules by the liver.
Intravascular delivery of siRNA molecules is a very simple technique, which was used to
protect mice from fulminant hepatitis using siRNAs against Fas receptors by Song et al. [28],
who administer Fas siRNA by intravenous injection into mice over a 24-hour period. The
authors could show the persist effects for 10 days and protected mice against experimentally
induced liver fibrosis. Local delivery of siRNAs have also been tried into the eye to target the
VEGF pathway and shown that it could be therapeutically beneficial in neovascularization-
related eye diseases. SiRNA topical gels have also been used to deliver them to cells in
dermatological applications and cervical cancer treatment [29]. Gene gun method was used
for an intradermal administration of nucleic acids to enhance cancer vaccine potency [30]. The
other technique is an electroporation, which has been used to deliver siRNAs into the brain
[31] and muscles of rodents. Injecting viral vectors for the in vivo delivery of siRNA directly
have been tried, where an adeno-associated virus (AAV) associated shRNA vector injected
directly into the midbrain neurons of adult mice to silence of the tyrosine hydroxylase gene
near the site of injection for several weeks. However, there exist an alternative to injection,
called as an ex vivo approach to generate human immunodeficiency virus (HIV)-1-resistant
lymphocytes and macrophages [32]. It was accomplished through using a lentiviral vector, an
anti-rev siRNA construct into CD34(+) hematopoietic progenitor cells. The siRNA-transduced
progenitor cells were allowed to mature into macrophages in vitro and T-cells in vivo, [33].
Many machine learning, bio-statistical [34] and association rule mining methods [35] are
available that have been developed to solve different problems related to gene silencing and
disease discovery. In this book chapter, we provided a comprehensive survey of different
machine learning and association rule mining algorithms developed for tackling various
biological challenges such as detection of gene signature, biomarker, gene module, potentially
disordered protein detection, differentially methylated region, multi-omics data integration,
etc. We also described a comparative study of different well-known classifiers along with other
used methods for the study. Meanwhile, many gene module discovery based approaches are
also developed that employs several machine learning, deep learning and soft computing
approaches. In addition, many multi-objective algorithms are also developed to find optimal
multi-omics genetic signatures for the respective disease. Furthermore, we demonstrated the
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brief biological information regarding the immense biological challenges for gene activation
and their advantages, disadvantages and possible therapeutic strategies. There are certain
challenges exist, such as off-target effects, cytotoxicity, need for efficient delivery methods,
their clinical implementation need efficient delivery vehicles and siRNA activity, itself, non-
specific gene silencing, activation of innate immune system, the lack of efficient in vivo deliv-
ery systems still remain to be handled. Apart from these challenges, the development of
efficient tissue-specific and differentiation dependent expression of siRNA is essential for
transgenic and therapeutic approaches. However, there are successful in vitro and in vivo
experiments for raising hopes in treating human diseases with RNAi [36]. Moreover, our study
is useful for the researchers to understand the central idea about RNAi and gene silencing,
along with the current machine/deep learning and association rule mining algorithms related
to these (Figure 1).
2. Fundamental concepts
In this section, some basic symbols of the graph mining, pattern recognition, [39] and informa-
tion theory are described. A graph is an ordered pair G = (V, E) comprising of a set of vertices
denoted as V and a set of edges denoted as E. To avoid ambiguity, the graph is described here
precisely as undirected and simple. Let, Q ¼ N;Eð Þ be an unweighted as well as undirected
Figure 1. Flowchart of the RNAi mechanism [37, 38].
Modulating Gene Expression - Abridging the RNAi and CRISPR-Cas9 Technologies108
graph, and H be a (hypograph) of it, (H ⊆ N). Further, suppose, the density of H, denoted by
Ds Hð Þ, be defined as Ds Hð Þ ¼ ∣IE Hð Þ∣
∣H∣ , where IE Hð Þ depicts the induced edge-set of H, and ∣H∣
refers to the cardinality of H. Suppose, the highest density of the graph H, referred to as
Ds∗ Hð Þ, is illustrated as follows: Ds∗ Hð Þ ¼ maxH⊆V DS Hð Þf g. Now, if Q ¼ N;Eð Þ is a weighted
graph, Ds Hð Þ will be
P
e∈ IE Hð Þ
wte
∣H∣ , where IE Hð Þ symbolizes the induced edge-set of H, and wte
denotes the weight of the edge e∈ IE Hð Þ. Entropy of a random variable evaluates the amount
of uncertainty corresponding to the variable [40]. The entropy of a discrete variable A, referred
to as EP Að Þ, is defined in the following: EP Að Þ ¼ 
P
a∈Ap að Þ log bp að Þ, where p að Þ refers to the
probability mass function of A, and the value of b, in general, is considered as 2. Mutual
information [41] between two random variables estimates the quantity of information that
they combinedly share, i.e., the mutual dependency between them. When mutual information
is zero, this signifies that these two variables are entirely independent to each other; whereas
when mutual information is higher, it signifies that these two variables are extremely depen-
dent on each other.
Topological Overlap Measure (TOM) and other related measures: Ravasz et al. [42] proposed a
new measure Topological Overlap Measure (TOM) that provided the similarity between two
nodes belonging to a network depending upon nearest neighbor concept. Furthermore, vari-
ous modified versions of TOM such as weighted TOM (wTOM) [43], generalized TOM
(GTOM) [44] are present in the literature. In the course of computing the wTOM, Pearson
correlation coefficient scores are first evaluated for all pairs of vertices, and then a soft
thresholding power (say, β >¼ 1) is utilized from the correlation coefficient matrix through
scale free topology. After that, weighted adjacency matrix is calculated using the coefficient
matrix using the calculated power β. Then wTOM is computed from the weighted adjacency
matrix. In the same way, the GTOM can also be defined just like TOM except it counts the
number of m-step neighbors while calculating TOM measure between two vertices. Now, for
calculating GTOM of order 0 (i.e., GTOM0), the adjacency score becomes the score of GTOM0.
But, for determining the GTOM with higher order than zero (i.e., GTOM1, GTOM2,
GTOM3,...), it follows the same procedure of TOM calculation, but counts up to €d-th neighbors
for each vertex (€d ¼ 1; 2; 3,…). Notably, GTOM1, GTOM2 and other higher order GTOMwork
only on binary matrix. So, before using those measures, the weighted adjacency matrix is
translated into binary matrix in which the greater adjacency value than a specified cutoff
(e.g., 70% score of the distance between the minimum and maximum adjacency values is
converted into 1, and the lower value than the cutoff is transferred into 0.
In data mining, hierarchical clustering is one of the most popular cluster analyses in forming a
hierarchy of clusters. There exist two types of strategies: agglomerative and divisive [45]. As is
already known, agglomerative hierarchical clustering does not need any input parameters
except the similarity matrix. Thus, there is no extra burden of utilizing cluster initialization as
it simply merges two closest clusters at each iteration and continues till a singleton cluster is
found. Divisive hierarchical clustering also follows the same style but in a reverse order. This is
the major benefit of performing hierarchical clustering over the traditional K-means clustering
algorithm, which is sensitive to initialization.
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Association rule mining (ARM) [46] is a popular method for generating interesting relation-
ships among different items (viz., genes). Suppose, GST ¼ g1; g2;…; gn
 
be a item set (gene
set) and SST ¼ s1; s2;…; smf g be sample set (viz., transaction set). Therefore, an association rule
can be stated as A) C, where A,C ⊆ GST and A ∩C ¼ ϕ. Notably, A and C symbolize as
antecedent and consequent, respectively. An association rule can be described as the cause-
effect relationships of the corresponding item sets in the transactions of a transactional data-
profile in a big shopping market. A set of bought items may fall into a transaction. In a similar
fashion, many genes may occur together in a sample (transaction) of a gene expression profile
or similar profile. Many of these genes may be up-regulated or down-regulated, whereas the
remaining genes will be non-differentially expressed.
3. Machine learning and rule mining approaches for gene inactivation
Currently, omics data analysis is one of the widely popular research domains. It can be
categorized into two major types, single-omics data analysis, and multi-omics data analysis.
In earlier, single-omics data processing such as gene expression data processing was highly
popular. In those days, basically microarray gene expression data was popular. Now, the
microarray data becomes obsolete while RNAseq, next-generation sequencing (NGS) and
whole exome sequencing (WES) data become popular. However, the major aim of the single
omics data analysis was to identify genetic marker as well as gene module identification. In
current era, multi-omics data integration is now a big challenge to any researcher since it
consists of various kind of profiles that are either proportional or inversely proportional to
each other. Different kinds of regression analysis (logistic regression, sglasso [47, 48], flasso
[47], etc.) are popular to integrate the multi-omics data. In case of the multi-omics data, the aim
is to determine either single (or, combinatorial) gene marker, or gene signature, or multi-
biomolecular closed bio-circuit. There are many machine learning and association rule mining
methods available that have been developed to solve different problems related to gene
silencing and disease discovery (Table 1 for tools and Table 2 for their application). For this
regard, Bandyopadhyay et al. provided a comprehensive survey of various statistical tests for
determining differentially expressed transcripts from microarray or other related datasets [69].
Then a rank based weighted association rule mining, RANWAR is developed to identify
weighted interesting genomic rules applicable to any kind of genomic or epigenomic data [9].
A new technique of gene-based association rule mining approach was developed in [62]. Next,
another statistics-based association rule mining technique “StatBicRM” had been proposed
that utilized statistical test and Binary Inclusion maximal algorithm (BiMax) to find
classification-based genetic rules [46]. Reverently, further enhancement of “StatBicRM” algo-
rithm was performed and a new method of combinatorial marker discovery had been devel-
oped whose central concept was based upon the inverse relationship between the gene
expression and methylation pattern [50]. In addition, mutual information based feature selec-
tion strategy had been incorporated into the statistical methodology, and a new method of
identifying epigenetic biomarkers through maximal relevance and minimal redundancy based
feature (gene) selection method from bi-omics dataset was proposed [63]. A new method of
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Method name Reference Type Brief description
Multi-view gene modules using
hypograph mining
Bhadra et al. [49] Gene-module
detection
Module detection from multi-view data
using the statistical test and mutual
information based dense subgraph.
RANWAR Mallik et al. [9] Rank based
genomic rule
mining
Rank based weighted association rule
mining to identify interesting genomic rules
applicable to any genomic/epigenomic data.
Combinatorial marker discovery
by integrating multiple profiles
Bandyopadhyay
et al. [50]
Combinatorial
marker discovery
Integrating gene expression and
methylation profiles, and identifying
combinatorial gene markers.
DTFP-growth Mallik et al. [51] Gene based ARM Multiple-threshold based ARM integrating
gene expression, methylation and protein-
protein interaction profiles.
StatBicRM Maulik et al. [46] Statistical
biclustering-based
rule mining
Statistical biclustering-based rule mining
and analyzing the gene expression and
methylation data profiles using it.
sglasso Augugliaro
[47, 48]
Regression method Sglasso tool develops the structured
graphical lasso estimator for the weighted
l1-penalized RCON(V, E) model.
flasso Augugliaro
[47, 52]
Regression method Implements the weight l1-penlized factorial
dynamic Gaussian graphical model.
MVDA Serra et al. [53] Multi-view
genomic profile
integration
Works to conjoin the those kinds of data at
the levels of the outcomes of every single
view clustering iteration.
Machine learning for epigenetics
and future medical applications
Holder et al. [54] Machine learning
and deep learning
approaches
Active learning and imbalanced class
learning are utilized to solve the
shortcoming with machine learning for
building better feature selection and solving
the imbalance data problem.
A machine learning approach to
integrate big data for precision
medicine
Lee et al. [55] Molecular marker
discovery
The robust molecular markers that might be
useful for targeted treatment of the acute
myeloid leukemia are identified.
Deep learning based multi-omics
integration robustly predicts
survival
Chaudhary
et al. [56]
Deep learning
based multi-omics
integration method
A deep learning method is used to integrate
multi-omics data and to perform survival
study on hepatocellular carcinoma.
Deep learning for genomics: a
concise overview
Yue et al. [57] Deep learning
applications on
genomic data
The strengths of various deep learning
methodologies are demonstrated that are
applicable on any kind of genomic profile.
intNMF Chalise and
Fridley [58]
Integrative
clustering method
Integrative clustering of several high
dimensional profiles and subtype
classification by non-negative matrix
factorization (NMF).
Multi-modal data analysis for
heterogeneous data
Yang and
Michailidis [59]
Module detection
for heterogeneous
data
The multi-modal profile analysis is
conducted for heterogeneous data
depending upon NMF.
Comparative study and
evaluation of the integrative
techniques for the multilevel
omics data
Pucher et al. [60] Integrative method
for multilevel
omics profiles
The comparative study of three integrative
methods (viz., NMF, sparse canonical
correlation analysis (sCCA) and logic data
mining MicroArray Logic Analyzer
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identifying multi-view gene-module identification was also proposed that applied the inte-
grated methodology of statistical method and dense subgraph mining [49]. Detection of
strongly connected genetic modules in multi-omics regulatory networks is an important study
for the integrated study analysis of the network-based architecture. Many profiles belonging to
the multi-omics datasets basically consist of a massive amount of genes, many of them are
noisy and redundant. Such kind of noisy and redundant genes (or, features) are irrelevant
while obtaining knowledge from the data. Furthermore, it is computationally absurd to utilize
any clustering technique on such type of huge sized data profiles to get the dense genetic
Method name Reference Type Brief description
(MALA)) is conducted on simulated data
and real omics profile.
WeCoMXP Mallik and
Bandyopadhyay
[61]
Weighted
connectivity
(similarity)
measure
WeCoMXP is developed integrating co-
expression, co-methylation and protein-
protein interactions, and useful for
determining the similarity between any two
molecules.
Tumor prediction using
integrated analysis of expression
and methylation
Mallik et al. [62] Rule-based
classifier
Integrated analysis of gene expression and
DNA methylation and classification rule
mining for tumor/cancer prediction.
Epigenetic gene marker discovery
through feature selection
Mallik et al. [63] Gene based ARM Epigenetic gene marker discovery using
maximal relevance and minimal
redundancy based feature selection.
Table 1. The machine learning and rule mining methods related to gene inactivation and RNAi.
Method name Reference Type Brief description
TF-MiRNA-gene network
based modules for cytosine
variants
Sen et al.
[64]
Module detection TF-MiRNA-gene network based module
detection for 5hmC and 5mC brain samples
between human and rhesus.
IDPT Mallik
et al. [65]
Intrinsically disordered
protein finding
Potential intrinsically disordered protein
identification through transcriptomic analysis
of genes for epigenetic data.
Integration of DNA
methylation data and gene
expression data
Singh
et al. [66]
Finding differentially
methylated regions
Differentially methylated regions are
determined and further statistical analysis is
performed.
Application of machine-
learning algorithms for gene
expression regulation
Cheng
and
Worzel
[67]
Applications of machine
learning methods on gene
regulation
The machine learning strategies on gene
regulation are reviewed, and their functional
links mediated by histone modifications and
transcription factors are demonstrated.
Application of machine-
learning techniques on
histone methylation
Xu et al.
[68]
Predictive model of gene
expression by epigenetic
factors by regression
A new model is developed to predict the gene
expression using the function of histone
modification levels through multi-linear
regression multivariate adaptive regression
splines.
Table 2. Applications of machine learning and rule mining methods related to gene inactivation.
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clusters. In many times, researchers face problems while calculating and subsequently accu-
mulating the similarity matrix of such massive dimensions consisting of all the mutual depen-
dency information between all the possible gene-pairs equivalent to every such profile. So,
managing the high dimensionality of the underlying profile is a critical challenge to the
researchers. To overcome the “curse of dimensionality” problem, the job of feature selection is
basically treated as one of the most important preprocessing works to remove such noisy and
redundant genes, which in turn decreases the total elapsed time. The main purpose of the
feature selection is to find an optimal subset of features depending on some optimization
conditions by which efficient knowledge discovery can be performed [70]. Depending on the
availability of the class labels, the feature selection process can be organized into two types:
supervised and unsupervised [71]. Unsupervised feature selection does not need the class label
information while choosing the minimized feature subset [72], whereas supervised feature
selection selects a subset of favorable features by utilizing the knowledge of class labels into
the feature selection procedure. In the case of supervised feature selection, significant test [73],
mutual information [74], are some broadly used measures to evaluate the excellence of the
candidate features. In the territory of biological rematches, a statistical test is generally treated
as one of the important tools for obtaining the significant genes for the big sized datasets, and
therefore aids in decreasing the size of the dataset. There are different types of statistical tests
such as t-test, significant analysis of microarrays, empirical Bayes test, etc. in the literature.
The significant genes therefore provide a weighted graph in which the nodes refer to the
significant genes and the weighted edges signify the association between the related two
nodes. Recently, graph data can be obtained in different rising fields of studies for forming
the complicated structures viz., biological networks, chemical compounds, social networks,
protein structures, etc. With the increasing stipulate on the analysis of large sized structured
data, graph mining has become one of the most demanding topics of research for identifying
the critical relationships among various entities included in the large graphs [75]. In the recent
era, analyzing multi-omics dataset is one of the emerging topics of research where different
profiles denoting several directions are applied to carry out different important tasks viz.,
marker determination, classification, and clustering. For this regard, many research works
have been performed in the following directions viz., marker identification [76], classification
[77], clustering [78], etc. Recently, Bhadra et al. [49] have developed a new algorithm handling
an integrated study comprising of statistical method and normalized mutual information
oriented hypo-graph mining to find the multi-omics co-similar genetic modules present in
multi-omics datasets. Formerly, various statistical (viz., correlation, regression oriented) and/
or weight-based techniques (viz., [79]) are matured for multi-omics data integration, but not for
multi-omics genetic-module detecting. Furthermore, some multi-view data integration mech-
anism employs various soft-computing methods such as clustering, non-matrix factorization,
etc. Recently, Serra et al. [53] proposed a framework for combining different data profiles of
multi-view datasets by integrating several clustering results done on each profile through non-
matrix factorization. Pucher et al. [60] provided a comprehensive review and comparative
study of the three integrative methods (viz., non-negative matrix factorization (NMF), sparse
canonical correlation analysis (sCCA) and logic data mining MicroArray Logic Analyzer
(MALA)) on simulated data as well as real omics profile. In addition, there are many deep
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learning techniques that were also developed to handle biological data. Chaudhary et al. [56]
proposed a deep learning based methodology to integrate multi-omics data and robustly
perform survival study on hepatocellular carcinoma. Furthermore, there are many interesting
applications of the above machine learning and deep learning techniques. For example, Xu
et al. [68] developed a new model using the regression to predict the gene expression using the
function of histone modifications/variants levels through the consecutive regression methods
(viz., multi-linear regression as well as multivariate adaptive regression splines). Mallik et al.
[65] performed a comprehensive analysis to identify potential intrinsically disordered proteins
through the transcriptomic analysis of genes for the expression and methylation data. To find
differentially methylated regions is also an area of interest. Comparison of different classifiers
used in many tools related to RNAi and gene inactivation is described in Table 3.
4. Biological challenges for gene inactivation
There are certain challenges exist, such as off-target effects, cytotoxicity, need for efficient
delivery methods, their clinical implementation need efficient delivery vehicles and siRNA
activity, itself, non-specific gene silencing, activation of innate immune system, the lack of
efficient in vivo delivery systems still remain to be handled [80]. The effective delivery of RNAi
therapeutics in vivo is one of the important challenge and have to consider several parameters
C4.5 classifier K-nearest
neighbors (KNN)
classifier
Naive Bayes
classifier
Support vector machines
(SVM) classifier
Artificial neural networks
(ANN) classifier
• Can use both
discrete and
continuous
values.
• Can use only
continuous
values.
• Can use both
discrete and
continuous
values.
• Can use only continuous
values.
• Can use both discrete
and continuous values.
• Handles
noise.
• Sensitive to
noisy features.
• Sensitive to
noisy features.
• Is less effective when
data contains noisy fea-
tures.
• Handles noisy features.
• Classes need
not be linearly
separable.
• Classes need
not be linearly
separable.
• Classes need
not be linearly
separable.
• Works well even if data is
not linearly separable in
the input feature space.
• Works fine even if data is
not linearly separable in
the input feature space.
• Faces the
problem of
overfitting.
• Overcomes the
problem of
overfitting.
• Faces the prob-
lem of
overfitting.
• Overcomes the problem
of overfitting.
• Overcomes the problem
of overfitting.
• Needs large
searching
time.
• Requires
higher
searching time
for a larger
data.
• Enormous
Computational
efficiency.
• Needs higher searching
time for a larger data.
• Needs high processing
time if neural network is
huge.
Table 3. Comparison of different classifiers.
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for an efficient silencing, particle sizing, duration of the RNAi effect, its stability and modifica-
tion, the delivery system and clearing off-target effects [81]. Apart from these challenges, the
development of efficient tissue-specific and differentiation dependent expression of siRNA is
essential for transgenic and therapeutic approaches. Bioactive drugs have been shown to
perturb the naturally running system as these can clog/saturate the biochemical pathways.
Since siRNA/shRNA relies on the endogenous microRNA machinery, thereby high doses of
ectopic RNA have the risk of saturating all component of the miRNA pathway components.
This was observed in the work by Grimm et al. [82] observed fatality association with high
doses of liver-directed AAV-encoded shRNAs in mice, where high doses killed the recipient
mice within 2 months. The length threshold of siRNAs seems to vary among cell types and it is
an important consideration as dsRNA would induce innate immune responses that would
eventually lead to cell death in mammalian. However, dsRNA less than 30 nucleotides have
been shown good enough for no induction of cellular toxicity in mammalian and longer
dsRNA is known to rapidly induce interferon responses. This suggests the careful risk assess-
ment strategies when using longer and more potent Dicer substrates siRNAs. Moreover,
correct RNAi targets are must, though ideal specificity of RNAi targets has not been shown.
However if RNAi is going to silence off-targets, it can alter the gene function, which is clearly
undesirable, therefore, care should be taken before-hand not to suppress the off-targets. If one
third of siRNA are chosen randomly that it results in a toxic phenotype [83]. Comparison of
siRNA and miRNA is described Table 4. However, there are successful in vitro and in vivo
experiments for raising hopes in treating human disease with RNAi. The epigenetic network
is one of the complex regulatory networks where epigenetic mechanisms such as DNA
siRNA miRNA
• Must be fully complementary to its target mRNA. • Can be partially complementary to its target mRNA.
• 21–23 nucleotide RNA duplex, notably endoge-
nous siRNAs’ origin is more polemic.
• 19–25 nucleotide RNA duplex, derived from gene units.
• dsRNA (30–100 nucleotides), before Dicer
processing.
• Precursor miRNA (70–100 nucleotides) with interspersed mis-
matches and hairpin structure, prior to Dicer processing.
• One mRNA target. • Can have multiple targets (>100 at the same time).
• For gene regulation, endonucleolytic cleavage of
mRNA occurs.
• For gene regulation, translational repression degradation of
mRNA occurs.
• Used as a therapeutic agent. • Utility as a drug target therapeutic agent Diagnostic and bio-
marker tool.
• siRNAs shut down gene expression at a post-
transcriptional level through mRNA degradation.
• MiRNAs silence their target genes mainly and most of the
times through translational repression.
• Occurs in plants and lower animals, occurrence in
mammals is questionable.
• Occurrence in plants and animals.
• Rarely found as an evolutionary conserved. • Evolutionary conserved most of the time in the related organ-
ism.
Table 4. Comparison of siRNA and miRNA.
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methylation and modifications to histone proteins regulate gene expression and high-order
DNA structure [84]. Epigenetics is basically a study of heritable changes in phenotypes where
the DNA sequences are not changed anymore. DNA methylation [85] is an epigenetic factor
that represents the inclusion of a methyl group (–CH3) to the fifth position of a cytosine
pyrimidine ring or to the sixth nitrogen position of an adenine purine ring in genomic DNA.
DNA methylation generally decreases belong to the gene expression level. In this connection,
copy number variation (CNV) [86] is another latest domain of research in genomics. It is
basically an event where the repetition of different portions of the genome continuously
happens, and an alteration on the number of repeats in the genome is recognized between
individual to individual in the human population. Copy number variation is a category of
structural changes, especially, it is a type of either duplication or deletion event which gener-
ally influences a reasonable number of base pairs. It has been realized from recent researches
that around two-thirds of the total human genome is made up of repeats. In the case of
mammals, copy number alteration provides a significant contribution on producing the neces-
sary deviation in both the population and disease phenotype. Cancer forms by various types of
somatic genetic changes including copy-number alternations which affect the activity of the
critical genes regulating the growth of the cell. Disadvantages and advantages of RNAi, and
possible overcome strategies are demonstrated briefly in Table 5.
5. Conclusion
RNAi and gene inactivation are well-known research topics in the research of biomedical field.
MiRNA and siRNA are closely associated with RNAi. Various categories of algorithms associ-
ated with RNAi and gene silencing have been developed in last 2 decades. In this book
Disadvantages Advantages and possible therapeutic strategies
• RNAi-based therapeutics has led to trigger several off-
target (unintended) effects and hence shown host innate
immune responses.
• Strategies for selective internalization and with endoge-
nous mechanism without disrupting the natural path-
way should be used to achieve maximal benefit from
RNAi-based therapeutics.
• Pol III expressed shRNAs delivered in an AAV deliv-
ered in mice tail vein through injection was lethal due to
acute liver failure.
• Levels of ectopic expression of therapeutic shRNAs
should be carefully controlled (low yet effective) to avoid
off target effects.
• Using naked siRNA has poor cellular uptake, it acti-
vates toll-like receptors and does not target to specific
cell types.
• Naked siRNA are comparatively stable and non-
immunogenic.
• Viral vectors for shRNA, expensive to create and cause
immune reactions.
• High affinity toward infecting target cells, expression can
long last.
• Lack of efficient delivery systems is the most critical
challenge for the therapeutic applications of small
RNAs.
• Identify the critical problem from the literature and
allow researchers to publish failed ideas.
Table 5. Disadvantages, advantages of RNAi and possible therapeutic strategies.
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chapter, we provided a comprehensive review of various machine/deep learning as well as
association rule mining algorithms that have been developed for handling different biological
problems such as gene signature detection, multi-omics data integration, single/combinatorial
biomarker identification, gene module detection, potentially disordered protein detection,
differentially methylated region finding, and many more. Thereafter, a comparative study of
several well-known classifiers along with other used approaches for the study has been
included. In addition, we provided a brief biological description of the immense biological
challenges for the gene activation along with their advantages, disadvantages and possible
therapeutic strategies. Finally, this chapter helps the bioinformaticians to understand the
central idea of RNAi and gene silencing along with their peripheral machine/deep learning
and association rule mining algorithms for the benevolent of the disease discovery as well as
possible therapeutic values.
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